Valuation
- Market cap
- 1,432,000
- Revenue TTM
- $0
- Net income TTM
- $-5,530,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 68,903
- Avg volume
- 132,478
- Day's range
- $0.52 – $0.63
- Shares out
- 1,935,000
- Stochastic %K
- 25%
- Beta
- 0.51
- Analysts
- Strong Buy
- Price target
- $4.00
Company profile
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 212 994 8200
- Website
- https://www.protagenic.com
- Address
- 149 Fifth Avenue, New York, United States
Latest news
No headlines yet.
